Skip to content

Clinical Study on Syndrome Differentiation and Treatment of Cardiac Palpitations (Atrial Fibrillation) in Traditional Chinese Medicine

Clinical Study on Syndrome Differentiation and Treatment of Cardiac Palpitations (Atrial Fibrillation) in Traditional Chinese Medicine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030517
Enrollment
Unknown
Registered
2020-03-05
Start date
2020-04-15
Completion date
Unknown
Last updated
2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Interventions

Sponsors

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-85 years. 2. Paroxysmal atrial fibrillation with frequency of two or more monthly or persistent atrial fibrillation (at least one ECG diagnosis). 3. The main syndromes of TCM syndrome differentiation are Qi deficiency and phlegm turbidity or Qi deficiency and yin deficiency. 4. Have a correct understanding of the significance of this research, have good compliance with the researchers' observations and evaluations, accept clinical trials voluntarily and fill in the consent.

Exclusion criteria

Exclusion criteria: 1. Patients with primary diseases such as severe pulmonary, liver, renal insufficiency, and hematopoietic system or severe heart dysfunction (NYHA class IV). 2. There are obvious incentives such as atrial fibrillation caused by fatigue, nervousness, mood swings, drug poisoning, and electrolyte disturbances. 3. People with mental illness and poor control. 4. Patients with a heart rate of less than 50 beats per minute (such as sick sinus node syndrome, atrioventricular or intraventricular block, etc., intended to install pacemakers). 5. Pregnant or lactating women. 6. Malignant Tumors in the End Stage. 7. Those who cannot determine the efficacy or incomplete information for various reasons.

Design outcomes

Primary

MeasureTime frame
holter;Cumulative number and duration of palpitations per week;Increasing or decreasing rate of basic medicine for western medicine;pro-BNP;EKG;Echocardiography;

Countries

China

Contacts

Public ContactNuo Tang

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

tangnuo2002@163.com+86 13370287093

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026